Silver Creek Pharmaceuticals
Kris Kuchenbecker is currently holding the position of Chief Science & Technology Officer at Silver Creek Pharmaceuticals since January 2021. Prior to this role, Kris studied in the Graduate Group in Biophysics at UCSF as a student under advisor Robert Fletterick. Kris also conducted research at the Thoracic Oncology Lab at UCSF from June 2004 to September 2006. Kris obtained a BA in Biochemistry/Molecular Biology from the University of California, Berkeley in 2004.
This person is not in the org chart
This person is not in any teams
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals, a biotechnology company, develops protein therapeutics to treat cardiovascular diseases. The company's mission is to provide smart growth factors to those suffering from organ damage as a result of an acute injury. Scp776 is currently being tested in clinical trials for the treatment of stroke.